Related Experiment Video
Updated: May 18, 2026
07:03
Large Scale Zebrafish-Based In vivo Small Molecule Screen
Published on: December 30, 2010
In situ hybridization assay-based small molecule screening in zebrafish
Lili Jing1, Ellen M Durand, Catherine Ezzio
1Stem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston, Harvard Medical School, Boston, MA.
Current Protocols in Chemical Biology
|September 25, 2012
Summary
Zebrafish whole-organism screening offers a powerful alternative to in vitro methods for identifying effective small molecules. This approach assesses in vivo compound activity early, improving drug discovery success rates.
Area of Science:
- Pharmacology and Toxicology
- Developmental Biology
- Genetics and Genomics
Background:
- In vitro small molecule screens often fail in animal models due to poor in vivo pharmacokinetics and toxicity.
- Zebrafish (Danio rerio) offer a vertebrate whole-organism model for early assessment of in vivo compound efficacy and specificity.
- Zebrafish are amenable to large-scale chemical screening, mirroring the throughput of cellular assays.
Purpose of the Study:
- To describe a protocol for in situ hybridization (ISH)-based chemical screening in zebrafish.
- To enable the identification of small molecules targeting specific gene products and molecular pathways in vivo.
- To provide a versatile platform adaptable for various screening readouts in zebrafish.
Main Methods:
- Development and application of an in situ hybridization (ISH) based chemical screening protocol in zebrafish.
- Utilizing zebrafish as a whole-organism model for assessing small molecule bioactivity and specificity.
- Adapting the protocol for screening diverse gene products and biological processes.
Main Results:
- Successfully identified small molecules impacting specific molecular pathways and biological processes using the ISH-based zebrafish screen.
- Demonstrated the feasibility of large-scale, in vivo chemical screening in zebrafish.
- Validated the utility of zebrafish for early evaluation of compound absorption, metabolism, and toxicity.
Conclusions:
- Zebrafish ISH-based screening provides a robust method for identifying bioactive small molecules with improved in vivo relevance.
- This whole-organism approach enhances the predictive value of early-stage drug discovery by addressing in vivo compound behavior.
- The protocol's adaptability supports broad applications in chemical biology and therapeutic development.
